Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction.

[1]  R. Califf,et al.  Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group. , 1992, Journal of the American College of Cardiology.

[2]  G. Wagner,et al.  Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time-activity curve. , 1991, American heart journal.

[3]  S. Hohnloser,et al.  Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. , 1991, Journal of the American College of Cardiology.

[4]  E. Topol,et al.  Coronary angiography after thrombolytic therapy for acute myocardial infarction. , 1991, Annals of internal medicine.

[5]  R. Califf,et al.  Evaluation of Combination Thrombolytic Therapy and Timing of Cardiac Catheterization in Acute Myocardial Infarction: Results of Thrombolysis and Angioplasty in Myocardial Infarction–Phase5 Randomized Trial , 1991, Circulation.

[6]  A. Jaffe,et al.  Prompt detection of coronary recanalization by analysis of rates of change of concentrations of macromolecular markers in plasma , 1991 .

[7]  K. Lee,et al.  Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. , 1990, The American journal of cardiology.

[8]  P. Gurbel,et al.  Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty. , 1990, The American journal of cardiology.

[9]  R. Califf,et al.  Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. , 1990, Journal of the American College of Cardiology.

[10]  G. Wagner,et al.  Relative increase in creatine kinase MB isoenzyme during reperfusion after myocardial infarction is method dependent. , 1990, Clinical chemistry.

[11]  D. Collen.  Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? , 1990, Annals of internal medicine.

[12]  M. Krucoff,et al.  The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion. , 1990, The American journal of cardiology.

[13]  R. Stack,et al.  Results of high dose intravenous urokinase for acute myocardial infarction. , 1990, The American journal of cardiology.

[14]  L. Hillis,et al.  Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. , 1989, The American journal of cardiology.

[15]  J. Bigger,et al.  A physiologically based model of creatine kinase-MB release in reperfusion of acute myocardial infarction. , 1989, The American journal of cardiology.

[16]  E. Braunwald,et al.  Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.

[17]  F. Klocke,et al.  Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction. , 1988, Circulation.

[18]  E. Braunwald,et al.  Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. , 1988, The American journal of cardiology.

[19]  B. Lewis,et al.  Usefulness of a rapid initial increase in plasma creatine kinase activity as a marker of reperfusion during thrombolytic therapy for acute myocardial infarction. , 1988, The American journal of cardiology.

[20]  H. Katus,et al.  Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. , 1988, European heart journal.

[21]  R. Califf,et al.  Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. , 1988, Annals of internal medicine.

[22]  R. Califf,et al.  Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. , 1988, Circulation.

[23]  H. Gold,et al.  Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. , 1988, Journal of the American College of Cardiology.

[24]  S. Chierchia,et al.  Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. , 1987, The New England journal of medicine.

[25]  K. Lee,et al.  A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.

[26]  E. Barlow,et al.  Immunochemiluminometric assay of creatine kinase MB with a monoclonal antibody to the MB isoenzyme. , 1987, Clinical chemistry.

[27]  R. Roberts,et al.  Creatine kinase isoform analysis in the detection and assessment of thrombolysis in man. , 1987, Circulation.

[28]  E. Topol,et al.  Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. , 1987, The American journal of cardiology.

[29]  E. Topol,et al.  Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction. , 1986, The American journal of cardiology.

[30]  M. Krucoff,et al.  Noninvasive detection of coronary artery patency using continuous ST-segment monitoring. , 1986, The American journal of cardiology.

[31]  F. Harrell,et al.  Predicting outcome in coronary disease. Statistical models versus expert clinicians. , 1986, The American journal of medicine.

[32]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[33]  J L Ritchie,et al.  The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. , 1985, The New England journal of medicine.

[34]  J L Ritchie,et al.  Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. , 1983, The New England journal of medicine.

[35]  J. Herlitz,et al.  Prognosis of acute myocardial infarction in relation to age , 1990 .

[36]  R. Califf,et al.  Long-term survival from acute myocardial infarction: salutary effect of an open coronary vessel. , 1990, The American journal of medicine.

[37]  J. Fleiss,et al.  Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. , 1988, The American journal of cardiology.

[38]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.

[39]  M. Miller,et al.  Immunochemical determination of CK-MB isoenzyme in human serum. II. An enzymic approach. , 1982, Clinical chemistry.

[40]  D. H. Mellor,et al.  Real time , 1981 .